Literature DB >> 22039326

Role of cyclooxygenase-2 gene polymorphisms in pancreatic carcinogenesis.

Renata Talar-Wojnarowska1, Anita Gasiorowska, Marek Olakowski, Pawel Lampe, Beata Smolarz, Hanna Romanowicz-Makowska, Ewa Malecka-Panas.   

Abstract

AIM: To evaluate the clinical significance of -765G/C and -1195G/A cyclooxygenase-2 (COX-2) gene polymorphisms in patients with pancreatic cancer (PC).
METHODS: The study included 201 patients: 85 with PC and 116 healthy controls. -765G/C and -1195G/A COX-2 gene polymorphisms were studied in DNA isolated from blood samples. The associations of the analyzed genotypes and clinical data at diagnosis were evaluated.
RESULTS: We found an increased frequency of the homozygous -1195AA COX-2 genotype in patients with PC (53.7%) compared with the control group (21%) (P < 0.01). In contrast, the distribution of genotype and allele frequencies of the -765G/C COX-2 polymorphism in the PC patients were not different from those in control groups. A correlation between presence of homozygous -1195AA COX-2 genotype and tumor size > 3 cm was observed (P < 0.05). Analyzed polymorphisms were unrelated to the patients' sex and age, nor to the presence of regional or distant metastases.
CONCLUSION: These preliminary results indicate that the -1195G/A COX-2 polymorphism may play an important role in PC prognosis and carcinogenesis.

Entities:  

Keywords:  Carcinogenesis; Cyclooxygenase-2; Pancreatic cancer; Polymorphisms

Mesh:

Substances:

Year:  2011        PMID: 22039326      PMCID: PMC3203363          DOI: 10.3748/wjg.v17.i36.4113

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  22 in total

Review 1.  COX-2 as a target for cancer chemotherapy.

Authors:  Nilanjan Ghosh; Rituparna Chaki; Vivekananda Mandal; Subhash C Mandal
Journal:  Pharmacol Rep       Date:  2010 Mar-Apr       Impact factor: 3.024

2.  Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer.

Authors:  Nan Bi; Ming Yang; Li Zhang; Xiabin Chen; Wei Ji; Guangfei Ou; Dongxin Lin; Luhua Wang
Journal:  Clin Cancer Res       Date:  2010-03-23       Impact factor: 12.531

3.  COX-2 polymorphisms -765G-->C and -1195A-->G and colorectal cancer risk.

Authors:  Juliët H Hoff; Rene H M te Morsche; Hennie M J Roelofs; Elise M J van der Logt; Fokko M Nagengast; Wilbert H M Peters
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

4.  Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response.

Authors:  Anastasia Papafili; Michael R Hill; David J Brull; Robin J McAnulty; Richard P Marshall; Steve E Humphries; Geoffrey J Laurent
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-10-01       Impact factor: 8.311

5.  Clinical value of serum neopterin, tissue polypeptide-specific antigen and CA19-9 levels in differential diagnosis between pancreatic cancer and chronic pancreatitis.

Authors:  Renata Talar-Wojnarowska; Anita Gasiorowska; Marek Olakowski; Andrzej Lekstan; Paweł Lampe; Ewa Malecka-Panas
Journal:  Pancreatology       Date:  2011-01-18       Impact factor: 3.996

6.  Tumor size significantly correlates with postoperative liver metastases and COX-2 expression in patients with resectable pancreatic cancer.

Authors:  Gaku Matsumoto; Mariko Muta; Koji Tsuruta; Shinichiro Horiguchi; Katsuyuki Karasawa; Atsutake Okamoto
Journal:  Pancreatology       Date:  2007-06-21       Impact factor: 3.996

7.  Cyclooxygenase-2 polymorphisms and the risk of esophageal adeno- or squamous cell carcinoma.

Authors:  Jón O Kristinsson; Paul van Westerveld; Rene H M te Morsche; Hennie M J Roelofs; T Wobbes; Ben J M Witteman; Adriaan C I T L Tan; Martijn G H van Oijen; Jan B M J Jansen; Wilbert H M Peters
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

8.  Interaction of cyclooxygenase-2 variants and smoking in pancreatic cancer: a possible role of nucleophosmin.

Authors:  Dan Zhao; Dongkui Xu; Xuemei Zhang; Li Wang; Wen Tan; Yongli Guo; Dianke Yu; Hui Li; Ping Zhao; Dongxin Lin
Journal:  Gastroenterology       Date:  2009-05       Impact factor: 22.682

9.  Genome-wide allelotypes of familial pancreatic adenocarcinomas and familial and sporadic intraductal papillary mucinous neoplasms.

Authors:  Tadayoshi Abe; Noriyoshi Fukushima; Kieran Brune; Corinne Boehm; Norihiro Sato; Hiroyuki Matsubayashi; Marcia Canto; Gloria M Petersen; Ralph H Hruban; Michael Goggins
Journal:  Clin Cancer Res       Date:  2007-10-15       Impact factor: 12.531

10.  COX-2 polymorphisms and colorectal cancer risk: a strategy for chemoprevention.

Authors:  Carina Pereira; Pedro Pimentel-Nunes; Catarina Brandão; Luís Moreira-Dias; Rui Medeiros; Mário Dinis-Ribeiro
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-05       Impact factor: 2.566

View more
  9 in total

1.  Cyclooxygenase-2 genetic polymorphism and stroke subtypes in Chinese.

Authors:  Guo-zhong Chen; Xiao-yun Shan; Gan-ping Cheng; Hong-miao Tao
Journal:  J Mol Neurosci       Date:  2013-08-02       Impact factor: 3.444

2.  Cyclooxygenase 2 genetic polymorphism may increase the risk of developing leukoaraiosis in Chinese.

Authors:  Xiao-yun Shan; Guo-zhong Chen; Gan-ping Cheng; Hong-miao Tao
Journal:  J Mol Neurosci       Date:  2013-07-13       Impact factor: 3.444

3.  Cyclooxygenase-2 -1195G>A (rs689466) polymorphism and cancer susceptibility: an updated meta-analysis involving 50,672 subjects.

Authors:  Yafeng Wang; Heping Jiang; Tianyun Liu; Weifeng Tang; Zhiqiang Ma
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  Functional Polymorphisms in COX-2 Gene Are Correlated with the Risk of Oral Cancer.

Authors:  Dong Li; Shu-Hong Hao; Yan Sun; Chun-Mei Hu; Zhi-Hua Ma; Zhi Ming Wang; Jie Liu; Hong Bo Liu; Ming Ye; Yu Fei Zhang; Dong Sheng Yang; Guang Shi
Journal:  Biomed Res Int       Date:  2015-04-21       Impact factor: 3.411

Review 5.  Immune response in thyroid cancer: widening the boundaries.

Authors:  Laura Sterian Ward
Journal:  Scientifica (Cairo)       Date:  2014-09-25

6.  Influence of CYP2C9 and COX-2 Genetic Polymorphisms on Clinical Efficacy of Non-Steroidal Anti-Inflammatory Drugs in Treatment of Ankylosing Spondylitis.

Authors:  Yu Wang; Xiao-Dong Yi; Hai-Lin Lu
Journal:  Med Sci Monit       Date:  2017-04-12

7.  TFAP2B overexpression contributes to tumor growth and progression of thyroid cancer through the COX-2 signaling pathway.

Authors:  Xiaoyan Fu; Huayong Zhang; Zhipeng Chen; Zhongyuan Yang; Dingbo Shi; Tianrun Liu; Weichao Chen; Fan Yao; Xuan Su; Wuguo Deng; Miao Chen; Ankui Yang
Journal:  Cell Death Dis       Date:  2019-05-21       Impact factor: 8.469

Review 8.  Multiple roles of dihomo-γ-linolenic acid against proliferation diseases.

Authors:  Xiaoping Wang; Huanping Lin; Yan Gu
Journal:  Lipids Health Dis       Date:  2012-02-14       Impact factor: 3.876

9.  COX-2 expression and tumor angiogenesis in thyroid carcinoma patients among northeast Chinese population-result of a single-center study.

Authors:  Bai Ji; Yahui Liu; Ping Zhang; Yingchao Wang; Guangyi Wang
Journal:  Int J Med Sci       Date:  2012-04-19       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.